-
-
Call more information
660-596-2224 -
ASA Monitor December 2024, Vol. 88, 28–29. Johns Hopkins Medicine study finds commonly used arm positions can overestimate blood pressure readings A study led by Johns Hopkins Medicine researchers concludes that commonly used ways of positioning the patient’s arm during blood pressure (BP) screenings can substantially overestimate test results and may lead to a misdiagnosis of […]
Read MoreASA Monitor December 2024, Vol. 88, 28–29. CMS establishes additional payment for iovera° in outpatient settings Pacira BioSciences, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) issued its final Medicare Hospital Outpatient Prospective Payment System and Medicare Ambulatory Surgical Center (ASC) Payment System rule for 2025, which implements the Non-Opioids Prevent Addiction in […]
Read MoreAuthor: Lalitha Sundararaman, MD, FASA ASA Monitor December 2024, Vol. 88, 33–34. Figure: Dosing considerations in the patients with obesity. Obesity has risen to new heights and encompasses 23% of the world’s population. Obesity in adolescents has increased four-fold over the last two decades. The use of GLP-1 receptor agonists has grown exponentially. In addition, there […]
Read MoreAuthors: Shahla Siddiqui, MBBS, MSc, FCCM et al ASA Monitor December 2024, Vol. 88, 1–5. The conflict between an individual physician’s duty to treat versus their personal issues of conscience and moral integrity has become more complex in recent years (Clinical Ethics: A Practical Approach to Ethical Decisions in Clinical Medicine. 8th edition, 2015). The loss of […]
Read MoreASA Monitor December 2024, Vol. 88, 28–29. FDA approves Exact Sciences’ Cologuard Plus test Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today announced the U.S. Food and Drug Administration (FDA) approved the Cologuard Plus™ test, the company’s next generation multitarget stool DNA test. The Cologuard Plus test is now approved for […]
Read More